This Is What Metabolic Dysfunction–Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol
AM Fischer, N Lechea, HO Coxson - Seminars in Liver Disease, 2024 - thieme-connect.com
Metabolic dysfunction–associated steatotic liver disease (MASLD) is a prevalent condition
with a broad spectrum defined by liver biopsy. This gold standard method evaluates three …
with a broad spectrum defined by liver biopsy. This gold standard method evaluates three …
MEFIB‐Index and MAST‐Score in the assessment of hepatic decompensation in metabolic dysfunction‐associated steatosis liver disease—Individual participant data …
N Noureddin, V Ajmera, J Bergstrom… - Alimentary …, 2023 - Wiley Online Library
Background There are limited data regarding the longitudinal association between MEFIB‐
Index (MRE combined with FIB‐4) versus MAST‐Score (MRI‐aspartate aminotransferase) …
Index (MRE combined with FIB‐4) versus MAST‐Score (MRI‐aspartate aminotransferase) …
Liver function indicators and risk of hepatocellular carcinoma: a bidirectional mendelian randomization study
S Qin, J Wang, H Yuan, J He, S Luan, Y Deng - Frontiers in Genetics, 2024 - frontiersin.org
Observational studies have shown an association between liver dysfunction and
hepatocellular carcinoma (HCC), but the causality relationship between them is unclear. We …
hepatocellular carcinoma (HCC), but the causality relationship between them is unclear. We …
Monitoring disease progression in metabolic dysfunction‐associated steatotic liver disease
N Noureddin, N Copur‐Dahi… - Alimentary Pharmacology …, 2024 - Wiley Online Library
Background Metabolic dysfunction‐associated steatotic liver disease (MASLD) is the most
common cause of chronic liver disease. Its prevalence is increasing with the epidemic of …
common cause of chronic liver disease. Its prevalence is increasing with the epidemic of …
Enhanced Liver Fibrosis Score for Diagnosing Liver Fibrosis in Chronic Hepatitis
N Tamaki, K Takaura, M Higuchi, Y Yasui, J Itakura… - Diagnostics, 2024 - mdpi.com
Background and aims: The enhanced liver fibrosis (ELF) score is a blood test that combines
three markers linked to liver fibrosis. The utility of the ELF score has been demonstrated …
three markers linked to liver fibrosis. The utility of the ELF score has been demonstrated …
Diagnosis and non‐invasive assessment of MASLD in type 2 diabetes and obesity
Background Metabolic dysfunction‐associated steatotic liver disease (MASLD) is currently
the most common chronic liver disease and an important cause of cirrhosis and …
the most common chronic liver disease and an important cause of cirrhosis and …
Reply to:“Non-invasive testing for advanced fibrosis in patients with diabetes with fatty liver disease needs further evaluation of cut-off values”
There are limited prospective data on patients with type 2 diabetes mellitus (T2DM)
specifically enrolled and systematically assessed for advanced fibrosis or cirrhosis due to …
specifically enrolled and systematically assessed for advanced fibrosis or cirrhosis due to …
Rising MASLD Cases in the US: How Can Health Care Systems Prepare?
M Rao - gastroenterologyadvisor.com
Male-patient-answers-questions-from-the-nurse-before-seeing-the-doctor Credit: Getty
Images With a 23% projected increase in MASLD cases in the US by 2050, researchers …
Images With a 23% projected increase in MASLD cases in the US by 2050, researchers …